Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Neurology|April 5, 2005
Phenotypic expression of familial amyloid polyneuropathy in BrazilP L Bittencourt, C A Couto, C Clemente, et al.
Parasite Immunology|March 10, 2001
Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malariaS L Avila, A C Goldberg, V G Arruk, et al.
The American Journal of Cardiology|January 23, 1999
Efficacy and safety of an extended-release niacin (Niaspan): a long-term studyD M Capuzzi, J R Guyton, J M Morgan, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1989
Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemiaE S Krul, M Kinoshita, P Talmud, et al.
Diabetes, Obesity & Metabolism|August 9, 2011
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease riskA F H Stalenhoef, M H Davidson, J G Robinson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 28, 1999
Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variantS A Palácios, P L Bittencourt, E L Cançado, et al.
Scandinavian Journal of Immunology|July 20, 2007
Autoimmune hepatitis in Brazil: an overviewA C Goldberg, P L Bittencourt, L C Oliveira, et al.
Human Immunology|April 21, 1998
HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada diseaseA C Goldberg, J H Yamamoto, J M Chiarella, et al.
Atherosclerosis|December 1, 1990
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosingD B Hunninghake, M J Mellies, A C Goldberg, et al.
Metabolism: Clinical and Experimental|September 29, 1998
Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemiaR H Knopp, P Alagona, M Davidson, et al.
Pageof 6